Capstone Therapeutics (NASDAQ:CAPS – Get Free Report) and Distribution Solutions Group (NASDAQ:DSGR – Get Free Report) are both small-cap industrials companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends and valuation.
Risk and Volatility
Capstone Therapeutics has a beta of -1.52, indicating that its share price is 252% less volatile than the S&P 500. Comparatively, Distribution Solutions Group has a beta of 0.54, indicating that its share price is 46% less volatile than the S&P 500.
Valuation & Earnings
This table compares Capstone Therapeutics and Distribution Solutions Group”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Capstone Therapeutics | $48.11 million | 0.08 | -$21.23 million | ($3.35) | -0.06 |
| Distribution Solutions Group | $2.05 billion | 0.78 | $8.35 million | $0.19 | 183.24 |
Distribution Solutions Group has higher revenue and earnings than Capstone Therapeutics. Capstone Therapeutics is trading at a lower price-to-earnings ratio than Distribution Solutions Group, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Capstone Therapeutics and Distribution Solutions Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Capstone Therapeutics | -36.51% | -144.43% | -40.48% |
| Distribution Solutions Group | 0.44% | 9.33% | 3.41% |
Insider and Institutional Ownership
2.5% of Capstone Therapeutics shares are held by institutional investors. Comparatively, 91.6% of Distribution Solutions Group shares are held by institutional investors. 39.3% of Capstone Therapeutics shares are held by company insiders. Comparatively, 78.8% of Distribution Solutions Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Analyst Recommendations
This is a summary of recent ratings for Capstone Therapeutics and Distribution Solutions Group, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Capstone Therapeutics | 1 | 0 | 0 | 0 | 1.00 |
| Distribution Solutions Group | 0 | 4 | 0 | 0 | 2.00 |
Distribution Solutions Group has a consensus target price of $35.00, suggesting a potential upside of 0.53%. Given Distribution Solutions Group’s stronger consensus rating and higher probable upside, analysts plainly believe Distribution Solutions Group is more favorable than Capstone Therapeutics.
Summary
Distribution Solutions Group beats Capstone Therapeutics on 13 of the 13 factors compared between the two stocks.
About Capstone Therapeutics
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.
About Distribution Solutions Group
Distribution Solutions Group, Inc., a specialty distribution company, engages in the provision of value-added distribution solutions in North America, Europe, Asia, South America, and the Middle East. The company provides its solutions to the maintenance, repair, and operations (MRO); original equipment manufacturer (OEM); and industrial technology markets. It operates through three segments: Lawson, Gexpro Services, and TestEquity. The Lawson segment distributes of specialty products and services to the industrial, commercial, institutional, and government MRO market. The TestEquity segment distributes test and measurement equipment and solutions, industrial and electronic production supplies, and vendor managed inventory programs, as well as converting, fabrication, and adhesive solutions under the TestEquity, Hisco, TEquipment, Techni-Tool, Jensen Tools, and Instrumex brands. The Gexpro Services segment provides supply chain management solutions that offer VMI, kitting, global logistics management, manufacturing localization and import expertise, value engineering, and quality assurance. The company was formerly known as Lawson Products, Inc. and has changed to Distribution Solutions Group, Inc. 2022 Distribution Solutions Group, Inc. was incorporated in 1952 and is headquartered in Fort Worth, Texas.
Receive News & Ratings for Capstone Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Capstone Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
